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of other classes of chemicals. But somehow the LDSO figure has gained a totally
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The Basis of the Argument
Measurement is very important in
science. Early lessons in the science classroom involve teaching students to measure lengths, volumes, weights, specific
gravities and anything else within the
mental and economic compass of the
teacher. At the same time, the question
of significance is drummed into the
students' heads. Thus, if one has a
meter-rule which is subdivided into centimeters (but not millimeters), one is
taught that the measurement of its length
to one decimal point (for example, 10.3 em)
is acceptable, but that the addition of
any more figures (for example, 10.325 em)
is mere braggadocio. The eye can only
make a rough guess at the subdivision between the centimeter divisions, and adding more figures after the decimal point
does not improve the accuracy of the estimate.
However, adding more numbers, without increasing the accuracy of the measurement, is precisely what is being attempted when the LD50 is used as a measure
of the acute toxicity of chemicals. (The
LD50 is the amount of a substance which,
if administered in a single dose to a target
group of animals, will kill 50 percent of
them). Normally, 50 to 200 animals are
used to estimate the LD50 and provide
its standard deviation from the mean.
For some reason, regulators and some
toxicologists appear to believe that an
LD50 with its fiducial limits is more accurate and more relevant than a rough
estimate of the acute toxicity, an estimate that can be obtained by using as few
4

as six animals (rather than the 50-200 animals needed for an LD50).
The point at issue, therefore, is simply this: Animal welfare groups and many
toxicologists want to see the LDSO (performed on 50 or more animals) replaced
within the next year by a rough estimate
of acute toxicity. The regulatory authorities have so far resisted making the necessary changes.

History
In 1927, J.W. Trevan published his
classic report on toxicity determination,
in which he asserted that the median lethal
dose (or LD50), done in a large (50-200)
sample of animals, provided the most
accurate index of a chemical's toxicity
(Proc Roy Acad Soc 101 8:483-514). He
was, however, concerned mainly with
the accurate standardization, by biological methods, of those drugs that are not
available in a chemically pure form. For
example, each new batch of such important drugs as digitalis extract, insulin,
and diphtheria toxin had to be accurately standardized since the margin of safety between therapeutic and toxic doses
is so small. Even today, the U.S. Pharmacopoeia requires a bioassay standardization of powdered digitalis that involves
comparing the lethal dose in pigeons
against a reference standard.
However, the number of LD50 determinations used to standardize potent
biological therapeutics now represents
only a small proportion of the LD50 tests
conducted annually. Most LD50 testing
is done to provide a figure for the toxicity
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undeserved position as the toxicological
reference standard; it seems to be regarded in nearly the same light as such physical constants as melting point and specific gravity. But as Trevan and his colleagues recognized, the LDSO of a substance
is not a fixed value; it varies according to
many extraneous factors, sometimes by
substantial amounts (see Tables 1 and 2).
In the last 15 years, however, the
use of the LD50 as a toxicological standard has come in for increasing criticism
among toxicologists (see Arch Toxicol 47:
77-99, 1981 ). It is not that they deny the
need for some sort of rough numerical
estimate of acute toxicity in a mammalian species. Rather, they deny the utility
of the precise statistical figure that is
provided by the usual LD50 test. It is
most important that this point be clearly
recognized. The immediate argument
over the LD50 is not that we do not need
acute toxicity data, but that we can get
the kind of data we need from small-scale
tests in a few animals. We do not need
to kill as many animals as we do merely
to provide statistical precision.

Protest Against the LD50
In the last decade, animal welfare
criticism of the LDSO test has become increasingly vocal and sophisticated. In
England, such criticism prompted a relatively unusual initiative from the Home
Secretary. In 1977, he asked the Advisory Committee to the Cruelty to Animals
Act, 1876, to review the extent of the use
of the LD50 test, as well as the scientific
necessity and justification for the test in
its various applications. The Advisory
Committee listened to extensive evidence
from animal welfare critics and the scientific community. Interestingly, the
scientific and regulatory groups, while
more restrained in tone, were often just
as critical of the LD50 test as the animal
welfare groups.
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The Association of the British Pharmaceutical Industry concluded that:
"estimation of LD50 is not an essential
requirement to ensure the safety of all
new drugs. Adequate information regarding the acute toxicity, including the
acute lethality, of new drugs can often
be obtained by the use of smaller numbers of animals than are conventionally
used in LD50 determinations." The Chemical Industries Association proposed that
(1) regulatory agencies be discouraged
from demanding precise LD50 figures;
(2) emphasis be placed on the qualitative
data obtainable from small-scale acute
toxicity studies; and (3) no animal should
be administered a quantity greater than
5 g (or 5 ml) of a substance per kg of
body weight (the so-called Limit test).
The Scottish Home and Health Department noted that "there is no case to be
made for requiring LD50 tests to provide
a value with small fiducial limits. An approximate estimate suffices."
By contrast, the Medical Research
Council (MRC), after explaining that precise data on acute toxicity were not really necessary, concluded that "the LD50
test is the only reliable measure of acute
toxicity and yields a result with the least
possible expenditure of life." However,
they followed this assertion with a statement that only a simple test, using a small
number of animals, should be done to
assess the order of magnitude of a chemical's toxicity. Clearly, when the MRC
talked of the need for an LD50, they
really meant that what we need to perform in most cases is a small-scale acute
toxicity test.
Unfortunately, the MRC was not
the only group to confuse the notion of
small-scale acute toxicity testing with
the LD50 test. When the Home Office report finally appeared in 1979, their first
recommendation was that "LD50 tests
should be allowed to continue." Although
they qualified this recommendation by
5
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advising that only a small numbers of
animals need be used, the harm had been
done: A government enquiry had found
that LDSO tests needed to continue. I
cannot say that I, personally, found the
Committee's findings particularly surprising. When I gave testimony to the
Committee (on behalf of FRAME- for
whom I was working at the time), one of
the expert advisors was almost plaintive
in defending the toxicologist's need for a
baseline figure for acute toxicity (i.e.,
the LDSO) and the other did not appear
to accept the distinction between smallscale acute toxicity testing and the full
LDSO.

Recent Developments
Despite the setback presented by
the 1979 report from the British Home
Office, there are now some encouraging
signs that an unlikely alliance of animal
welfare and industrial organizations
may prevail upon regulatory bodies and
effect a revolution in acute toxicity
testing. For example, if regulatory bodies
would agree to prohibit the submission
of LDSO figures except in those few cases
where scientific justification can be provided for an LDSO determination, we
would reduce the number of animals used
in determining lethal doses by about
80-90 percent. Numerically, this would
probably amount to 2-4 million animal
lives saved every year. What events have
occurred to change the climate of opinion since 1979?
First, an international coalition of
animal welfare groups has been formed
with the specific aim of abolishing the
LDSO test. A similar coalition against the
Draize test was very successful (see lnt j
Stud Anim Prob 3:94-97), and there is
every reason to hope for similar success
if a concerted campaign can be mounted
over the next year. The immediate goal
will be to get the regulatory agencies to
switch from tacit or explicit requirements
for LDSO data to an explicit prohibition
6

on the submission of LDSO data, unless
accompanied by scientific justification.
Second, on October 21, 1982, the
Pharmaceutical Manufacturers Association (U.S.) called for a revision of government regulations so that fewer animals
are used in drug safety evaluation. They
specifically noted that "the classical
LDSO test which utilizes many animals
to determine an LDSO value with mathematical precision lacks justification ... "
They proposed that: (1) the precise determination of an LDSO should be limited
to those rare cases where it is necessary;
(2) an approximate lethal dose plus qualitative data usually represents adequate
information on the acute toxicity of drugs;
and (3) there should be an international
effort to reach agreement among regulatory agencies that, for drugs, a precise
LDSO determination is not necessary.
Third, at a number of recent scientific meetings, the overwhelming consensus has been that the LDSO is unnecessarily precise- qualitative and semiquantitative data from small-scale acute
toxicity tests is usually adequate. For example, at a FRAME conference, pharmaceutical company staff in the audience
voted to abolish the LDSO test by 20 to 1
(New Scientist, November 4, 1982, p. 275).
At a conference that specifically addressed the LDSO test in Sweden (September,
1981), a clinical toxicologist from the
Karolinska Poison Information Center
stated that the numerical information
provided by an animal LDSO is virtually
useless. Other scientific meetings on the
use of animals in acute toxicity testing
are planned. The indications are that
these meetings will confirm the uselessness of precise LDSO data. All this activity on the part of scientists, combined
with animal welfare protests, should escalate the pressure to the point that regulatory bodies are forced to take action.

Conclusion
A reassessment of the need for LDSO
figures is long overdue. Bureaucrats may
/NT I STUD ANIM PROB 4(1) 1983
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not be comfortable with approximate lethal dose figures, but there are clearly few
cases where LDSO determinations amount
to anything more than pseudoscientific
nonsense. LDSO testing continues, not because it receives broad endorsement but
because nobody feels sufficiently s~cure
to take the decisive action that is neces-

sary to eradicate 40 years of thoughtless
tradition. Since death by poisoning cannot
be particularly pleasant, regulatory agencies that are serious about animal welfare issues ought to begin to take steps
to abolish unnecessary LDSO testing, especially since the scientific verdict
against it is already in.

TABLE 1 Human Acute lethal Doses and Animal LD50's (Oral)
Human
LDLo
(mg/kg)

Amytal
Boric Acid
Caffeine
Carbofuran
Lindane
Fenflurazole
Cycloheximide

43
640
192
11
840

Animal LD50
Rat

560
2660
192
5
125
238
3

Mouse

Rabbit

Dog

575
3450
620
2
1600
133

130
28

120
65

Compiled from CRC Handbook of Analytical Toxicology and the NIOSH Registry of Toxic Effects of ChemIcal Substances

TABLE 2 Range of LD50 Values for Five Compounds Tested Under Similar
Conditions in 65 Different European Toxicology Laboratories

LD50 Range (mg/kg)
Compound

PCP
Na Salicylate
Aniline
Acetanilide
Cadmium Chloride

Laboratories That Used
Their Own Protocol

46-522
800-4150
350-1280
805-5420
70-513

Laboratories That Used
The Standard Protocol

74-2328
930-2328
479-1169
723-3060
105-482

Compiled from I Assoc Off Anal Chern 62:864-873, 1979, and Arch Toxico/47:77-98, 1981
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